120 related articles for article (PubMed ID: 30578659)
1. Proteome Analyses Reveal Positive Association of COL2A1, MPO, TYMS, and IGFBP5 with Canine Mammary Gland Malignancy.
Wu CC; Chang SC; Zeng GY; Chu HW; Huang Y; Liu HP
Proteomics Clin Appl; 2019 Jul; 13(4):e1800151. PubMed ID: 30578659
[TBL] [Abstract][Full Text] [Related]
2. Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours.
Chang SC; Yuan SH; Li CY; Chang HM; Wang HC; Pan YA; Hsueh PC; Wu CC; Yang Y; Liu HP
Vet Comp Oncol; 2021 Mar; 19(1):172-182. PubMed ID: 33038064
[TBL] [Abstract][Full Text] [Related]
3. The Implication of Serum Autoantibodies in Prognosis of Canine Mammary Tumors.
Yuan SH; Chang SC; Chou PY; Yang Y; Liu HP
Animals (Basel); 2022 Sep; 12(18):. PubMed ID: 36139323
[TBL] [Abstract][Full Text] [Related]
4. Relationship between receptors for insulin-like growth factor- I, steroid hormones and apoptosis-associated proteins in canine mammary tumors.
Dolka I; Motyl T; Malicka R; Sapierzyński E; Fabisiak M
Pol J Vet Sci; 2011; 14(2):245-51. PubMed ID: 21721409
[TBL] [Abstract][Full Text] [Related]
5. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells.
Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP
Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
7. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
van Garderen E; Schalken JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of expression of the Wnt signaling components in canine mammary tumors via RT
Yu F; Rasotto R; Zhang H; Pei S; Zhou B; Yang X; Jin Y; Zhang D; Lin D
J Vet Sci; 2017 Sep; 18(3):359-367. PubMed ID: 27586466
[TBL] [Abstract][Full Text] [Related]
9. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
10.
Schabort JJ; Nam AR; Lee KH; Kim SW; Lee JE; Cho JY
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218035
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of mammaglobin-B in canine mammary tumors.
Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
[TBL] [Abstract][Full Text] [Related]
13. Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours.
Jakab C; Halász J; Szász AM; Kiss A; Schaff Z; Rusvai M; Gálfi P; Kulka J
J Comp Pathol; 2008 Nov; 139(4):238-45. PubMed ID: 18848337
[TBL] [Abstract][Full Text] [Related]
14. CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.
Seung BJ; Lim HY; Shin JI; Kim HW; Cho SH; Kim SH; Sur JH
Vet Pathol; 2018 May; 55(3):417-424. PubMed ID: 29343199
[TBL] [Abstract][Full Text] [Related]
15. IGF-I and retinoic acid regulate the distribution pattern of IGFBPs synthesized by the canine mammary tumor cell line CMT-U335.
Oosterlaken-Dijksterhuis MA; Kwant MM; Slob A; Hellmén E; Mol JA
Breast Cancer Res Treat; 1999 Mar; 54(1):11-23. PubMed ID: 10369076
[TBL] [Abstract][Full Text] [Related]
16. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
[TBL] [Abstract][Full Text] [Related]
18. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
[TBL] [Abstract][Full Text] [Related]
19. Molecular carcinogenesis of canine mammary tumors: news from an old disease.
Klopfleisch R; von Euler H; Sarli G; Pinho SS; Gärtner F; Gruber AD
Vet Pathol; 2011 Jan; 48(1):98-116. PubMed ID: 21149845
[TBL] [Abstract][Full Text] [Related]
20. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
